West Pharmaceutical Services stock hits new 52-week high

10 articles · Updated · MarketWatch · May 8

Shares rose 1.21% to $325.92 on Friday, their fourth straight gain, topping the previous $323.63 peak set on 7 May.
The move came in a broadly stronger US market, with the S&P 500 up 0.84% and the Dow Jones Industrial Average edging 0.02% higher.
Trading volume reached 1.0 million shares, above the 50-day average of 915,564, while peers Abbott and Becton Dickinson fell and Baxter gained.

While West Pharma hits new highs, its rivals face massive lawsuits. What does this divergence signal for medtech investors?

With its successful CEO retiring, can West Pharmaceutical sustain its record-breaking momentum under new leadership?

How is smart packaging technology driving West Pharma's growth and reshaping the trillion-dollar injectable drug market?